Search Results - "GANZENKO, N"

Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer by ATHANASIADIS, I, KIES, M. S, MILLER, M, GANZENKO, N, JOOB, A, MARYMONT, M.-.A, RADEMAKER, A, GRADISHAR, W. J

“…Between April 1993 and June 1994, 29 patients (pts) with unresectable, locally advanced, or metastatic non-small cell lung cancer were treated with a…”
Get full text

How Do Head and Neck Cancer Patients Prioritize Treatment Outcomes Before Initiating Treatment? by LIST, M. A, STRACKS, J, VOKES, E. E, COLANGELO, L, BUTLER, P, GANZENKO, N, LUNDY, D, SULLIVAN, P, HARAF, D, KIES, M, GOODWIN, W

“…To determine, pretreatment, how head and neck cancer (HNC) patients prioritize potential treatment effects in relationship to each other and to survival and to…”
Get full text

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck a long term analysis for the Illinois Cancer Center by ATHANASIADIS, I, TAYLOR, S. IV, VOKES, E. E, PELZER, H. J, RADEMAKER, A, MITTAL, B. B, GANZENKO, N, BLOUGH, R, LESTER, E. P, KIES, M. S

“…In 1982, the Illinois Cancer Center initiated a Phase II trial in which the following treatment was administered: Induction chemotherapy (cisplatin and…”
Get full text